nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ABCC10—Cyclosporine—focal segmental glomerulosclerosis	0.232	0.296	CbGbCtD
Paclitaxel—ABCB11—Cyclosporine—focal segmental glomerulosclerosis	0.126	0.161	CbGbCtD
Paclitaxel—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.0896	0.114	CbGbCtD
Paclitaxel—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0663	0.0845	CbGbCtD
Paclitaxel—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.06	0.0764	CbGbCtD
Paclitaxel—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0443	0.0564	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0443	0.0564	CbGbCtD
Paclitaxel—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0332	0.0423	CbGbCtD
Paclitaxel—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0319	0.0407	CbGbCtD
Paclitaxel—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0223	0.0284	CbGbCtD
Paclitaxel—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0216	0.0275	CbGbCtD
Paclitaxel—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.0165	CbGbCtD
Paclitaxel—Hypotrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0754	CcSEcCtD
Paclitaxel—Breath sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.0371	CcSEcCtD
Paclitaxel—Haemolytic uraemic syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.0326	CcSEcCtD
Paclitaxel—Autonomic neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0313	CcSEcCtD
Paclitaxel—MAPT—nephron tubule—focal segmental glomerulosclerosis	0.00419	0.0699	CbGeAlD
Paclitaxel—MAPT—cortex of kidney—focal segmental glomerulosclerosis	0.00359	0.0598	CbGeAlD
Paclitaxel—Thrombotic thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.0249	CcSEcCtD
Paclitaxel—Polyneuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.0218	CcSEcCtD
Paclitaxel—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.0213	CcSEcCtD
Paclitaxel—MAP4—kidney—focal segmental glomerulosclerosis	0.0029	0.0483	CbGeAlD
Paclitaxel—MAP4—cortex of kidney—focal segmental glomerulosclerosis	0.00282	0.047	CbGeAlD
Paclitaxel—BCL2—kidney—focal segmental glomerulosclerosis	0.00263	0.0439	CbGeAlD
Paclitaxel—MAP2—cortex of kidney—focal segmental glomerulosclerosis	0.00222	0.037	CbGeAlD
Paclitaxel—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0154	CcSEcCtD
Paclitaxel—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00207	0.0345	CbGeAlD
Paclitaxel—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.0149	CcSEcCtD
Paclitaxel—MAPT—Reelin signaling pathway—VLDLR—focal segmental glomerulosclerosis	0.00202	0.113	CbGpPWpGaD
Paclitaxel—TUBB2B—nephron tubule—focal segmental glomerulosclerosis	0.00194	0.0323	CbGeAlD
Paclitaxel—TUBB—nephron tubule—focal segmental glomerulosclerosis	0.00184	0.0306	CbGeAlD
Paclitaxel—TUBB2A—nephron tubule—focal segmental glomerulosclerosis	0.00183	0.0304	CbGeAlD
Paclitaxel—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0132	CcSEcCtD
Paclitaxel—TUBB6—nephron tubule—focal segmental glomerulosclerosis	0.0018	0.03	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00177	0.0295	CbGeAlD
Paclitaxel—TUBB4A—kidney—focal segmental glomerulosclerosis	0.00176	0.0294	CbGeAlD
Paclitaxel—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0124	CcSEcCtD
Paclitaxel—TUBB2B—cortex of kidney—focal segmental glomerulosclerosis	0.00166	0.0277	CbGeAlD
Paclitaxel—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0117	CcSEcCtD
Paclitaxel—TUBB6—kidney—focal segmental glomerulosclerosis	0.00158	0.0264	CbGeAlD
Paclitaxel—TUBB—cortex of kidney—focal segmental glomerulosclerosis	0.00157	0.0262	CbGeAlD
Paclitaxel—TUBB4B—nephron tubule—focal segmental glomerulosclerosis	0.00157	0.0261	CbGeAlD
Paclitaxel—TUBB2A—cortex of kidney—focal segmental glomerulosclerosis	0.00156	0.026	CbGeAlD
Paclitaxel—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0113	CcSEcCtD
Paclitaxel—TUBB6—cortex of kidney—focal segmental glomerulosclerosis	0.00154	0.0257	CbGeAlD
Paclitaxel—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0112	CcSEcCtD
Paclitaxel—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0111	CcSEcCtD
Paclitaxel—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.011	CcSEcCtD
Paclitaxel—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0106	CcSEcCtD
Paclitaxel—ABCC10—kidney—focal segmental glomerulosclerosis	0.00139	0.0231	CbGeAlD
Paclitaxel—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.01	CcSEcCtD
Paclitaxel—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.01	CcSEcCtD
Paclitaxel—TUBB4B—kidney—focal segmental glomerulosclerosis	0.00138	0.0229	CbGeAlD
Paclitaxel—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00995	CcSEcCtD
Paclitaxel—ABCC10—cortex of kidney—focal segmental glomerulosclerosis	0.00135	0.0225	CbGeAlD
Paclitaxel—TUBB4B—cortex of kidney—focal segmental glomerulosclerosis	0.00134	0.0223	CbGeAlD
Paclitaxel—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00944	CcSEcCtD
Paclitaxel—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00127	0.0211	CbGeAlD
Paclitaxel—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00921	CcSEcCtD
Paclitaxel—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00913	CcSEcCtD
Paclitaxel—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00906	CcSEcCtD
Paclitaxel—CYP1B1—nephron tubule—focal segmental glomerulosclerosis	0.00124	0.0207	CbGeAlD
Paclitaxel—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00884	CcSEcCtD
Paclitaxel—BCL2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00121	0.0675	CbGpPWpGaD
Paclitaxel—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00871	CcSEcCtD
Paclitaxel—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00815	CcSEcCtD
Paclitaxel—ABCC2—kidney—focal segmental glomerulosclerosis	0.00111	0.0185	CbGeAlD
Paclitaxel—CYP1B1—kidney—focal segmental glomerulosclerosis	0.00109	0.0182	CbGeAlD
Paclitaxel—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.00108	0.0181	CbGeAlD
Paclitaxel—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00787	CcSEcCtD
Paclitaxel—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00787	CcSEcCtD
Paclitaxel—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00782	CcSEcCtD
Paclitaxel—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00782	CcSEcCtD
Paclitaxel—CYP1B1—cortex of kidney—focal segmental glomerulosclerosis	0.00106	0.0177	CbGeAlD
Paclitaxel—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00771	CcSEcCtD
Paclitaxel—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00771	CcSEcCtD
Paclitaxel—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00766	CcSEcCtD
Paclitaxel—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00747	CcSEcCtD
Paclitaxel—MAP2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00101	0.0563	CbGpPWpGaD
Paclitaxel—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.000954	0.0159	CbGeAlD
Paclitaxel—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.000948	0.0069	CcSEcCtD
Paclitaxel—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.000943	0.00686	CcSEcCtD
Paclitaxel—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.000932	0.00679	CcSEcCtD
Paclitaxel—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.000927	0.00675	CcSEcCtD
Paclitaxel—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.000923	0.0154	CbGeAlD
Paclitaxel—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000917	0.00667	CcSEcCtD
Paclitaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTPRO—focal segmental glomerulosclerosis	0.000906	0.0506	CbGpPWpGaD
Paclitaxel—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.00653	CcSEcCtD
Paclitaxel—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.000892	0.0065	CcSEcCtD
Paclitaxel—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.00643	CcSEcCtD
Paclitaxel—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.00643	CcSEcCtD
Paclitaxel—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000857	0.0143	CbGeAlD
Paclitaxel—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000852	0.0062	CcSEcCtD
Paclitaxel—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.000847	0.00617	CcSEcCtD
Paclitaxel—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.000847	0.00617	CcSEcCtD
Paclitaxel—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000834	0.0139	CbGeAlD
Paclitaxel—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00588	CcSEcCtD
Paclitaxel—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.000792	0.00577	CcSEcCtD
Paclitaxel—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000785	0.00572	CcSEcCtD
Paclitaxel—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000771	0.00561	CcSEcCtD
Paclitaxel—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00552	CcSEcCtD
Paclitaxel—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000753	0.0125	CbGeAlD
Paclitaxel—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.000751	0.00547	CcSEcCtD
Paclitaxel—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.000748	0.00545	CcSEcCtD
Paclitaxel—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000745	0.00542	CcSEcCtD
Paclitaxel—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000733	0.0122	CbGeAlD
Paclitaxel—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000726	0.00529	CcSEcCtD
Paclitaxel—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000726	0.00529	CcSEcCtD
Paclitaxel—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.00527	CcSEcCtD
Paclitaxel—BCL2—Interleukin-11 Signaling Pathway—PIAS1—focal segmental glomerulosclerosis	0.000672	0.0375	CbGpPWpGaD
Paclitaxel—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000671	0.00489	CcSEcCtD
Paclitaxel—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000664	0.00483	CcSEcCtD
Paclitaxel—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00065	0.00473	CcSEcCtD
Paclitaxel—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.00471	CcSEcCtD
Paclitaxel—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000641	0.00466	CcSEcCtD
Paclitaxel—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000638	0.00465	CcSEcCtD
Paclitaxel—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00455	CcSEcCtD
Paclitaxel—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000617	0.00449	CcSEcCtD
Paclitaxel—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000613	0.00446	CcSEcCtD
Paclitaxel—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000601	0.00437	CcSEcCtD
Paclitaxel—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000597	0.00434	CcSEcCtD
Paclitaxel—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000589	0.00429	CcSEcCtD
Paclitaxel—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000573	0.00417	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000569	0.00414	CcSEcCtD
Paclitaxel—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.00412	CcSEcCtD
Paclitaxel—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000565	0.00942	CbGeAlD
Paclitaxel—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000558	0.00406	CcSEcCtD
Paclitaxel—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.00403	CcSEcCtD
Paclitaxel—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.00402	CcSEcCtD
Paclitaxel—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000549	0.004	CcSEcCtD
Paclitaxel—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000546	0.00398	CcSEcCtD
Paclitaxel—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000546	0.00398	CcSEcCtD
Paclitaxel—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00397	CcSEcCtD
Paclitaxel—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.00392	CcSEcCtD
Paclitaxel—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000537	0.00391	CcSEcCtD
Paclitaxel—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000535	0.0039	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000535	0.0039	CcSEcCtD
Paclitaxel—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000532	0.00388	CcSEcCtD
Paclitaxel—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000531	0.00387	CcSEcCtD
Paclitaxel—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000531	0.00387	CcSEcCtD
Paclitaxel—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000521	0.00379	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00376	CcSEcCtD
Paclitaxel—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.00375	CcSEcCtD
Paclitaxel—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000512	0.00373	CcSEcCtD
Paclitaxel—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00359	CcSEcCtD
Paclitaxel—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00358	CcSEcCtD
Paclitaxel—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00049	0.00357	CcSEcCtD
Paclitaxel—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00355	CcSEcCtD
Paclitaxel—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000487	0.00354	CcSEcCtD
Paclitaxel—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000484	0.00353	CcSEcCtD
Paclitaxel—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000482	0.00351	CcSEcCtD
Paclitaxel—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.0035	CcSEcCtD
Paclitaxel—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000473	0.00344	CcSEcCtD
Paclitaxel—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000457	0.00333	CcSEcCtD
Paclitaxel—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000455	0.00759	CbGeAlD
Paclitaxel—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000455	0.00331	CcSEcCtD
Paclitaxel—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000445	0.00324	CcSEcCtD
Paclitaxel—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000442	0.00322	CcSEcCtD
Paclitaxel—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00044	0.0032	CcSEcCtD
Paclitaxel—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.00319	CcSEcCtD
Paclitaxel—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000433	0.00315	CcSEcCtD
Paclitaxel—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00043	0.00313	CcSEcCtD
Paclitaxel—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000427	0.00311	CcSEcCtD
Paclitaxel—SLCO1B3—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000426	0.0238	CbGpPWpGaD
Paclitaxel—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00306	CcSEcCtD
Paclitaxel—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.00305	CcSEcCtD
Paclitaxel—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.00304	CcSEcCtD
Paclitaxel—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000415	0.00302	CcSEcCtD
Paclitaxel—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.00299	CcSEcCtD
Paclitaxel—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000402	0.00293	CcSEcCtD
Paclitaxel—ABCB1—kidney—focal segmental glomerulosclerosis	0.0004	0.00667	CbGeAlD
Paclitaxel—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0004	0.00291	CcSEcCtD
Paclitaxel—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00288	CcSEcCtD
Paclitaxel—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000395	0.00287	CcSEcCtD
Paclitaxel—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.00286	CcSEcCtD
Paclitaxel—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00039	0.00284	CcSEcCtD
Paclitaxel—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00039	0.00649	CbGeAlD
Paclitaxel—MAPT—LPA receptor mediated events—GNAQ—focal segmental glomerulosclerosis	0.000387	0.0216	CbGpPWpGaD
Paclitaxel—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000385	0.0028	CcSEcCtD
Paclitaxel—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000383	0.00279	CcSEcCtD
Paclitaxel—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000382	0.00278	CcSEcCtD
Paclitaxel—BCL2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000373	0.0209	CbGpPWpGaD
Paclitaxel—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000372	0.00271	CcSEcCtD
Paclitaxel—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00037	0.00269	CcSEcCtD
Paclitaxel—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000369	0.00268	CcSEcCtD
Paclitaxel—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNAQ—focal segmental glomerulosclerosis	0.000364	0.0203	CbGpPWpGaD
Paclitaxel—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00265	CcSEcCtD
Paclitaxel—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00265	CcSEcCtD
Paclitaxel—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00265	CcSEcCtD
Paclitaxel—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000362	0.00264	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.00263	CcSEcCtD
Paclitaxel—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000359	0.00261	CcSEcCtD
Paclitaxel—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000355	0.00259	CcSEcCtD
Paclitaxel—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00256	CcSEcCtD
Paclitaxel—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000348	0.00254	CcSEcCtD
Paclitaxel—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000348	0.00254	CcSEcCtD
Paclitaxel—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000346	0.00252	CcSEcCtD
Paclitaxel—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000342	0.00249	CcSEcCtD
Paclitaxel—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.00248	CcSEcCtD
Paclitaxel—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.00246	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000338	0.0189	CbGpPWpGaD
Paclitaxel—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000337	0.00245	CcSEcCtD
Paclitaxel—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00242	CcSEcCtD
Paclitaxel—MAPT—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.000327	0.0182	CbGpPWpGaD
Paclitaxel—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000317	0.00231	CcSEcCtD
Paclitaxel—SLCO1B3—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000316	0.0176	CbGpPWpGaD
Paclitaxel—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.00229	CcSEcCtD
Paclitaxel—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000313	0.00228	CcSEcCtD
Paclitaxel—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00226	CcSEcCtD
Paclitaxel—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.00225	CcSEcCtD
Paclitaxel—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.00223	CcSEcCtD
Paclitaxel—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.0022	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000301	0.00219	CcSEcCtD
Paclitaxel—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.00219	CcSEcCtD
Paclitaxel—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000298	0.00217	CcSEcCtD
Paclitaxel—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000298	0.00217	CcSEcCtD
Paclitaxel—ABCB11—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000297	0.0166	CbGpPWpGaD
Paclitaxel—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.00209	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000285	0.00207	CcSEcCtD
Paclitaxel—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000277	0.00201	CcSEcCtD
Paclitaxel—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.002	CcSEcCtD
Paclitaxel—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.002	CcSEcCtD
Paclitaxel—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000257	0.00187	CcSEcCtD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000251	0.014	CbGpPWpGaD
Paclitaxel—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00025	0.00182	CcSEcCtD
Paclitaxel—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.00179	CcSEcCtD
Paclitaxel—MAPT—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.000246	0.0137	CbGpPWpGaD
Paclitaxel—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000238	0.00174	CcSEcCtD
Paclitaxel—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00023	0.00168	CcSEcCtD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000223	0.0125	CbGpPWpGaD
Paclitaxel—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000221	0.00161	CcSEcCtD
Paclitaxel—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.0016	CcSEcCtD
Paclitaxel—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000219	0.0016	CcSEcCtD
Paclitaxel—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00159	CcSEcCtD
Paclitaxel—CYP1B1—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000211	0.0118	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—COL4A4—focal segmental glomerulosclerosis	0.000209	0.0116	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000208	0.0116	CbGpPWpGaD
Paclitaxel—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.00151	CcSEcCtD
Paclitaxel—MAPT—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.000195	0.0109	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—COL4A1—focal segmental glomerulosclerosis	0.000192	0.0107	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—GNAQ—focal segmental glomerulosclerosis	0.000178	0.00993	CbGpPWpGaD
Paclitaxel—SLCO1B3—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000165	0.00922	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000158	0.00883	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000158	0.00882	CbGpPWpGaD
Paclitaxel—ABCB11—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000155	0.00868	CbGpPWpGaD
Paclitaxel—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000153	0.00853	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000149	0.00833	CbGpPWpGaD
Paclitaxel—MAPT—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000147	0.00818	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000144	0.00804	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000141	0.00789	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000137	0.00766	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—MMP2—focal segmental glomerulosclerosis	0.000128	0.00715	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000113	0.0063	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—PCNA—focal segmental glomerulosclerosis	0.000112	0.00625	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000108	0.00601	CbGpPWpGaD
Paclitaxel—BCL2—Interleukin-11 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.0001	0.0056	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	9.93e-05	0.00554	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.73e-05	0.00544	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—FN1—focal segmental glomerulosclerosis	9.51e-05	0.00531	CbGpPWpGaD
Paclitaxel—BCL2—IL-3 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	9.19e-05	0.00514	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—SPP1—focal segmental glomerulosclerosis	9.05e-05	0.00506	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—PCNA—focal segmental glomerulosclerosis	8.89e-05	0.00496	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	8.49e-05	0.00474	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—SERPINE1—focal segmental glomerulosclerosis	7.92e-05	0.00442	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	7.52e-05	0.0042	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	7.09e-05	0.00396	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	6.93e-05	0.00387	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—MMP2—focal segmental glomerulosclerosis	6.41e-05	0.00358	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—MYH9—focal segmental glomerulosclerosis	6.35e-05	0.00355	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	6.33e-05	0.00354	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—SERPINE1—focal segmental glomerulosclerosis	6.29e-05	0.00351	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	6.2e-05	0.00346	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.16e-05	0.00344	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.16e-05	0.00344	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.94e-05	0.00332	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—FN1—focal segmental glomerulosclerosis	5.92e-05	0.00331	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	5.87e-05	0.00328	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.76e-05	0.00322	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.63e-05	0.00314	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	5.58e-05	0.00312	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	5.55e-05	0.0031	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	5.48e-05	0.00306	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	5.37e-05	0.003	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.05e-05	0.00282	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	5.04e-05	0.00281	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TGFB1—focal segmental glomerulosclerosis	5e-05	0.00279	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIAS1—focal segmental glomerulosclerosis	4.99e-05	0.00279	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—focal segmental glomerulosclerosis	4.85e-05	0.00271	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	4.75e-05	0.00265	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	4.75e-05	0.00265	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.62e-05	0.00258	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	4.59e-05	0.00257	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	4.58e-05	0.00256	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.53e-05	0.00253	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	4.44e-05	0.00248	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	4.35e-05	0.00243	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	4.34e-05	0.00243	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.26e-05	0.00238	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.18e-05	0.00233	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	4.09e-05	0.00229	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—CTGF—focal segmental glomerulosclerosis	4.09e-05	0.00228	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.07e-05	0.00227	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.02e-05	0.00224	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.99e-05	0.00223	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	3.9e-05	0.00218	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—PCNA—focal segmental glomerulosclerosis	3.89e-05	0.00217	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	3.87e-05	0.00216	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.75e-05	0.0021	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—MYH9—focal segmental glomerulosclerosis	3.7e-05	0.00207	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	3.6e-05	0.00201	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	3.57e-05	0.00199	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.42e-05	0.00191	CbGpPWpGaD
Paclitaxel—SLCO1B3—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.39e-05	0.0019	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	3.3e-05	0.00184	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—PCNA—focal segmental glomerulosclerosis	3.22e-05	0.0018	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.21e-05	0.0018	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.2e-05	0.00179	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.1e-05	0.00173	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.1e-05	0.00173	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	3.01e-05	0.00168	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	3.01e-05	0.00168	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.99e-05	0.00167	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.95e-05	0.00165	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—PCNA—focal segmental glomerulosclerosis	2.95e-05	0.00165	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	2.91e-05	0.00162	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.83e-05	0.00158	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.82e-05	0.00157	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	2.81e-05	0.00157	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.76e-05	0.00154	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	2.75e-05	0.00154	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.73e-05	0.00152	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.6e-05	0.00145	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.6e-05	0.00145	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.54e-05	0.00142	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.54e-05	0.00142	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	2.47e-05	0.00138	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.45e-05	0.00137	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	2.44e-05	0.00136	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.38e-05	0.00133	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.36e-05	0.00132	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	2.36e-05	0.00132	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	2.36e-05	0.00132	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.32e-05	0.0013	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	2.28e-05	0.00127	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	2.26e-05	0.00126	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD79A—focal segmental glomerulosclerosis	2.24e-05	0.00125	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.22e-05	0.00124	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	2.21e-05	0.00123	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	2.16e-05	0.0012	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.09e-05	0.00117	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.07e-05	0.00116	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—LIPC—focal segmental glomerulosclerosis	2.02e-05	0.00113	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.96e-05	0.0011	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.95e-05	0.00109	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	1.94e-05	0.00108	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.91e-05	0.00107	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—LIPC—focal segmental glomerulosclerosis	1.9e-05	0.00106	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.89e-05	0.00106	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.87e-05	0.00105	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	1.86e-05	0.00104	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD40LG—focal segmental glomerulosclerosis	1.83e-05	0.00102	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.81e-05	0.00101	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CTGF—focal segmental glomerulosclerosis	1.77e-05	0.000991	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	1.77e-05	0.000989	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.75e-05	0.000976	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.72e-05	0.000963	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.71e-05	0.000953	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.68e-05	0.000937	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.67e-05	0.000933	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CTGF—focal segmental glomerulosclerosis	1.67e-05	0.000933	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.64e-05	0.000913	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.62e-05	0.000903	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.54e-05	0.00086	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.54e-05	0.000859	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.43e-05	0.0008	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.43e-05	0.000796	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.42e-05	0.000795	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.4e-05	0.000785	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.38e-05	0.00077	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.29e-05	0.000719	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.28e-05	0.000716	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.26e-05	0.000704	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.25e-05	0.000701	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.25e-05	0.000701	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.25e-05	0.0007	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.24e-05	0.000694	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.24e-05	0.000693	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.23e-05	0.000689	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—LPL—focal segmental glomerulosclerosis	1.23e-05	0.000687	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.22e-05	0.000681	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.21e-05	0.000678	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.16e-05	0.000649	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—LPL—focal segmental glomerulosclerosis	1.16e-05	0.000647	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.16e-05	0.000646	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.12e-05	0.000625	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.1e-05	0.000617	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.09e-05	0.000611	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.07e-05	0.000599	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.07e-05	0.000596	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AGT—focal segmental glomerulosclerosis	1.05e-05	0.000588	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—LPL—focal segmental glomerulosclerosis	1.04e-05	0.00058	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.02e-05	0.000568	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.01e-05	0.000563	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AGT—focal segmental glomerulosclerosis	9.91e-06	0.000553	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	9.24e-06	0.000516	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.12e-06	0.00051	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	8.99e-06	0.000502	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—LPL—focal segmental glomerulosclerosis	8.74e-06	0.000488	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—LPL—focal segmental glomerulosclerosis	8.7e-06	0.000486	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	8.68e-06	0.000485	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—LPL—focal segmental glomerulosclerosis	8.41e-06	0.00047	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOS2—focal segmental glomerulosclerosis	8.11e-06	0.000453	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ALB—focal segmental glomerulosclerosis	8.08e-06	0.000451	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	7.91e-06	0.000442	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	7.78e-06	0.000435	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	7.65e-06	0.000428	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ALB—focal segmental glomerulosclerosis	7.6e-06	0.000425	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	7.59e-06	0.000424	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AGT—focal segmental glomerulosclerosis	7.47e-06	0.000417	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AGT—focal segmental glomerulosclerosis	7.44e-06	0.000416	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	7.43e-06	0.000415	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.29e-06	0.000407	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AGT—focal segmental glomerulosclerosis	7.2e-06	0.000402	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7e-06	0.000391	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	6.85e-06	0.000383	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SERPINE1—focal segmental glomerulosclerosis	6.83e-06	0.000382	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.78e-06	0.000379	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	6.55e-06	0.000366	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	6.49e-06	0.000363	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	6.33e-06	0.000354	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.31e-06	0.000353	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	5.97e-06	0.000333	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.8e-06	0.000324	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—focal segmental glomerulosclerosis	5.74e-06	0.00032	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—focal segmental glomerulosclerosis	5.71e-06	0.000319	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.7e-06	0.000318	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	5.58e-06	0.000312	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—focal segmental glomerulosclerosis	5.52e-06	0.000309	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.5e-06	0.000307	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	5.48e-06	0.000306	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.14e-06	0.000287	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	5.02e-06	0.000281	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	4.98e-06	0.000278	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	4.75e-06	0.000265	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	4.69e-06	0.000262	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—focal segmental glomerulosclerosis	4.31e-06	0.000241	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.18e-06	0.000233	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.14e-06	0.000231	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	4.06e-06	0.000227	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	3.87e-06	0.000216	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	3.68e-06	0.000205	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	3.6e-06	0.000201	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	3.54e-06	0.000198	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.39e-06	0.000189	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	3.31e-06	0.000185	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	3.12e-06	0.000174	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.72e-06	0.000152	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.55e-06	0.000142	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	2.54e-06	0.000142	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.18e-06	0.000122	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.67e-06	9.35e-05	CbGpPWpGaD
